Navigation Links
Curcumin shows promise in attacking Parkinson's disease
Date:3/20/2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... it about toothpaste that transforms the sweet flavor of ... to that mysterious sensory phenomenon in colorful, animated ... Chemical Society,s award-winning Bytesize Science video series ... world,s largest scientific society, explains that the mainstay ingredients ... or SLS for short. When you brush your teeth, ...
(Date:5/20/2013)... 21, 2013) Wolters Kluwer Health ... & Wilkins (LWW) published journals won 13 ASHPE ... recognizes member articles and publications for editorial, design, ... tremendous honor to be recognized year after year ... in the industry with quality, depth, and impact," ...
(Date:5/20/2013)... Medicare Part D seniors in plans ... costs, convenient access to pharmacies and other benefits, according ... today by the Pharmaceutical Care Management Association (PCMA). More ... currently enrolled in plans with preferred networks. , “Seniors ... of plans with preferred pharmacy networks,” said PCMA President ...
(Date:5/20/2013)... Benefits of Pharmacy Home Delivery report was recently ... Pack announced. The new report offers helpful information ... provide useful details for those who are contemplating changing the ... owner and pharmacist said, “One of the biggest benefits of ... MedEx Pack, patients can receive their own pre-filled medication dispenser ...
(Date:5/20/2013)... new report suggests that improved health care and significant ... up the age-old relationship between physicians and drug company ... unnecessary prescription drugs. , This system, which has been ... by keeping them up to date on new medications, ... get patients started on the newest drugs, as well ...
Breaking Medicine News(10 mins):Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3
... be treated nonsurgically and high-level injuries often require surgery, ... of the Journal of the American Academy of ... surgeons still disagree on the best course of treatment ... , Shoulder separations, clinically known as acromioclavicular joint injuries, ...
... an important contribution to future clinical therapeutic approaches. The ... Nature and will be a central topic of ... which will take place in Munich from April 2nd ... mechanisms of blood formation (hematopoiesis) will be presented in ...
... Resources champions company,s effortsGAITHERSBURG, Md., April 1 ... in the category of Work Life for its ... disabilities and their families. The award was presented ... The integrated food and facilities management company and ...
... to treat a mid-level, common injury ROSEMONT, Ill., April 1 ... injuries often require surgery, a literature review published in the April ... of Orthopaedic Surgeons ( JAAOS ) finds that many ... injuries that fall in between., , ...
... Laboratories, Inc. Immunotech Laboratories announces successful Participation in ... its abstract " Irreversible Pepsin Fraction (IPF) displays ... in vitro investigation of activity on human lymphocytes." ... Conference on Clinical and Social Research on AIDS ...
... Need for Heightened Autism Awareness among Hispanic Community as ... Seals is shining the spotlight on its services for ... services, the national nonprofit provides for people with disabilities ... Seals has seen a dramatic increase in the number ...
Cached Medicine News:Health News:Healing a shoulder separation 2Health News:Last step leading to blood cell formation elucidated 2Health News:Sodexo Receives 2009 Disability Matters Award 2Health News:Sodexo Receives 2009 Disability Matters Award 3Health News:Healing a Shoulder Separation 2Health News:Healing a Shoulder Separation 3Health News:Beating a Global Killer: HIV/AIDS 2Health News:Beating a Global Killer: HIV/AIDS 3Health News:Beating a Global Killer: HIV/AIDS 4Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 3
(Date:5/20/2013)... 2013  Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...
(Date:5/20/2013)... 2013  AbbVie (NYSE: ABBV ) ... clinical study called SONAR (Study Of Diabetic Nephropathy ... investigational compound atrasentan - when added to standard of ... with stage 2 to 4 chronic kidney disease ... large, multinational, double-blind, placebo-controlled clinical study that is ...
(Date:5/20/2013)... -- With herbal medicines relied upon by consumers worldwide, ... Convention (USP) will provide freely available public standards to ... in these products. Today, USP proposes the first 23 ... Medicines Compendium ( HMC ) for comment by ... . HMC will provide standards for herbal ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3
... Formation in ... Animals, Hearts, SUNRISE, ... of myoblasts modified to express,stromal derived factor-1(alpha) protein (SDF-1) into the ... were recently,presented at two scientific meetings -- the International Society for,Magnetic ...
... Enrollment Program Speeds Oncology Patient Accrual, ... Research Management,Organization (RMO), has contracted with five ... management services for their,clinical trials using the ... the following disease indications: follicular Non-Hodgkin,s,Lymphoma, Metastatic ...
Cached Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2
Maddox Rod, short handle (12cm)...
Graham Field 10' Reversed Snellen Eye Chart....
... PacScan 300AP is a portable, ... provides easy-to-use touch screen operation. ... frequency, low noise probes and ... capture immediately upon application of ...
Precision that fits in the palm of your hand and measures down to 125 microns, the Pocket Pachymeter is about 8" X 4" x 2" and really does fit in a lab coat pocket or briefcase....
Medicine Products: